Home Data Calendar Blog

SHC

Tables

2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31

Weighted Average Number Of Diluted Shares Outstanding 280.17 280.17 279.91 NA 279.56 279.21 278.97 NA 232.40 232.40 232.40

Weighted Average Number Of Shares Outstanding Basic 280.14 279.99 279.83 NA 279.38 279.08 278.83 NA 232.40 232.40 232.40

Earnings Per Share Basic 0.09 0.11 0.11 0.12 0.10 0.15 0.04 -0.18 0.00 0.03 -0.01

Earnings Per Share Diluted 0.09 0.11 0.11 0.12 0.10 0.15 0.04 -0.18 0.00 0.03 -0.01

	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31
Weighted Average Number Of Diluted Shares Outstanding	280.17	280.17	279.91	NA	279.56	279.21	278.97	NA	232.40	232.40	232.40
Weighted Average Number Of Shares Outstanding Basic	280.14	279.99	279.83	NA	279.38	279.08	278.83	NA	232.40	232.40	232.40
Earnings Per Share Basic	0.09	0.11	0.11	0.12	0.10	0.15	0.04	-0.18	0.00	0.03	-0.01
Earnings Per Share Diluted	0.09	0.11	0.11	0.12	0.10	0.15	0.04	-0.18	0.00	0.03	-0.01

2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31

Revenue From Contract With Customer Excluding Assessed Tax 248.70 266.64 236.75 241.25 226.16 251.92 212.15 216.84 200.03 213.09 188.20

Revenues 248.70 266.64 236.75 241.25 226.16 251.92 212.15 216.84 200.03 213.09 188.20

Cost Of Revenue 112.69 116.24 107.88 107.30 100.58 108.16 96.78 96.27 92.52 94.12 91.68

Gross Profit 136.01 150.40 128.88 133.95 125.59 143.76 115.37 120.58 107.51 118.97 96.52

Operating Expenses 72.82 78.90 75.38 67.53 59.91 65.49 69.01 68.20 60.48 57.23 51.65

Selling General And Administrative Expense 57.09 63.13 59.54 51.83 44.04 49.83 52.47 53.16 45.63 42.68 37.05

Operating Income Loss 63.20 71.50 53.49 66.43 65.67 78.27 46.36 52.38 47.03 61.74 44.87

Interest Paid Net 22.99 26.25 15.81 5.05 17.11 16.87 19.75 47.31 51.24 49.16 63.57

Interest Income Expense Nonoperating Net -23.43 -14.04 -10.40 -15.61 -18.14 -19.16 -21.28 -48.12 -55.33 -55.25 -56.56

Income Tax Expense Benefit 16.93 17.69 14.63 22.74 13.66 19.18 3.02 8.31 -1.21 3.77 -12.23

Income Taxes Paid Net 19.13 23.84 13.51 20.09 9.14 11.22 11.56 14.34 6.32 1.46 1.87

Profit Loss 25.09 30.42 30.64 36.00 27.44 42.62 11.06 -43.39 0.63 7.25 -1.99

Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax 9.41 3.18 6.18 NA NA NA NA 0.00 1.83 1.47 -3.48

Net Income Loss 25.09 30.42 30.64 36.00 27.44 42.60 10.84 -43.68 0.01 7.02 -1.96

Comprehensive Income Net Of Tax -33.90 -11.91 51.52 58.38 -1.04 62.29 7.52 -12.35 18.53 31.96 -76.20

Net Income Loss Available To Common Stockholders Basic 24.87 30.11 30.30 35.56 27.10 42.02 10.69 -43.68 0.01 7.02 -1.96

Net Income Loss Available To Common Stockholders Diluted 24.87 30.11 30.30 35.56 27.10 42.02 10.69 -43.68 0.01 7.02 -1.96

	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31
Revenue From Contract With Customer Excluding Assessed Tax	248.70	266.64	236.75	241.25	226.16	251.92	212.15	216.84	200.03	213.09	188.20
Revenues	248.70	266.64	236.75	241.25	226.16	251.92	212.15	216.84	200.03	213.09	188.20
Cost Of Revenue	112.69	116.24	107.88	107.30	100.58	108.16	96.78	96.27	92.52	94.12	91.68
Gross Profit	136.01	150.40	128.88	133.95	125.59	143.76	115.37	120.58	107.51	118.97	96.52
Operating Expenses	72.82	78.90	75.38	67.53	59.91	65.49	69.01	68.20	60.48	57.23	51.65
Selling General And Administrative Expense	57.09	63.13	59.54	51.83	44.04	49.83	52.47	53.16	45.63	42.68	37.05
Operating Income Loss	63.20	71.50	53.49	66.43	65.67	78.27	46.36	52.38	47.03	61.74	44.87
Interest Paid Net	22.99	26.25	15.81	5.05	17.11	16.87	19.75	47.31	51.24	49.16	63.57
Interest Income Expense Nonoperating Net	-23.43	-14.04	-10.40	-15.61	-18.14	-19.16	-21.28	-48.12	-55.33	-55.25	-56.56
Income Tax Expense Benefit	16.93	17.69	14.63	22.74	13.66	19.18	3.02	8.31	-1.21	3.77	-12.23
Income Taxes Paid Net	19.13	23.84	13.51	20.09	9.14	11.22	11.56	14.34	6.32	1.46	1.87
Profit Loss	25.09	30.42	30.64	36.00	27.44	42.62	11.06	-43.39	0.63	7.25	-1.99
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax	9.41	3.18	6.18	NA	NA	NA	NA	0.00	1.83	1.47	-3.48
Net Income Loss	25.09	30.42	30.64	36.00	27.44	42.60	10.84	-43.68	0.01	7.02	-1.96
Comprehensive Income Net Of Tax	-33.90	-11.91	51.52	58.38	-1.04	62.29	7.52	-12.35	18.53	31.96	-76.20
Net Income Loss Available To Common Stockholders Basic	24.87	30.11	30.30	35.56	27.10	42.02	10.69	-43.68	0.01	7.02	-1.96
Net Income Loss Available To Common Stockholders Diluted	24.87	30.11	30.30	35.56	27.10	42.02	10.69	-43.68	0.01	7.02	-1.96

2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31

Assets 2810.63 2839.68 2835.77 2789.50 2742.74 2851.13 2777.00 2761.28 NA NA NA

Liabilities 2203.90 2203.68 2193.64 2203.41 2216.97 2327.86 2311.26 2306.70 NA NA NA

Liabilities And Stockholders Equity 2810.63 2839.68 2835.77 2789.50 2742.74 2851.13 2777.00 2761.28 NA NA NA

Stockholders Equity 606.73 636.00 642.13 586.10 525.77 523.27 463.26 452.30 NA NA NA

	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31
Assets	2810.63	2839.68	2835.77	2789.50	2742.74	2851.13	2777.00	2761.28	NA	NA	NA
Liabilities	2203.90	2203.68	2193.64	2203.41	2216.97	2327.86	2311.26	2306.70	NA	NA	NA
Liabilities And Stockholders Equity	2810.63	2839.68	2835.77	2789.50	2742.74	2851.13	2777.00	2761.28	NA	NA	NA
Stockholders Equity	606.73	636.00	642.13	586.10	525.77	523.27	463.26	452.30	NA	NA	NA

2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31

Assets Current 420.73 398.68 371.56 345.96 337.31 401.11 328.37 315.01 NA NA NA

Cash And Cash Equivalents At Carrying Value 163.97 139.56 121.44 106.92 114.91 156.22 108.01 102.45 NA NA NA

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 164.96 140.62 121.45 106.92 114.92 156.22 108.02 102.45 108.44 86.36 105.19

Accounts Receivable Net Current 111.61 119.85 114.76 108.18 96.09 118.41 96.39 91.73 NA NA NA

Inventory Net 37.15 39.65 45.70 54.29 37.50 35.72 33.38 34.09 NA NA NA

Inventory Finished Goods 5.43 5.96 12.62 8.98 2.90 6.16 2.62 4.26 NA NA NA

Inventory Raw Materials And Supplies 31.45 33.33 32.45 41.51 33.44 28.46 29.51 29.11 NA NA NA

Other Assets Current 11.13 11.57 16.36 7.31 10.80 8.28 11.76 8.02 NA NA NA

Prepaid Expense And Other Assets Current 81.67 81.17 83.96 71.92 67.71 67.94 69.76 64.96 NA NA NA

	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31
Assets Current	420.73	398.68	371.56	345.96	337.31	401.11	328.37	315.01	NA	NA	NA
Cash And Cash Equivalents At Carrying Value	163.97	139.56	121.44	106.92	114.91	156.22	108.01	102.45	NA	NA	NA
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents	164.96	140.62	121.45	106.92	114.92	156.22	108.02	102.45	108.44	86.36	105.19
Accounts Receivable Net Current	111.61	119.85	114.76	108.18	96.09	118.41	96.39	91.73	NA	NA	NA
Inventory Net	37.15	39.65	45.70	54.29	37.50	35.72	33.38	34.09	NA	NA	NA
Inventory Finished Goods	5.43	5.96	12.62	8.98	2.90	6.16	2.62	4.26	NA	NA	NA
Inventory Raw Materials And Supplies	31.45	33.33	32.45	41.51	33.44	28.46	29.51	29.11	NA	NA	NA
Other Assets Current	11.13	11.57	16.36	7.31	10.80	8.28	11.76	8.02	NA	NA	NA
Prepaid Expense And Other Assets Current	81.67	81.17	83.96	71.92	67.71	67.94	69.76	64.96	NA	NA	NA

2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31

Amortization Of Intangible Assets 20.22 21.20 20.18 21.44 21.24 21.78 22.28 20.43 20.20 19.71 19.91

Property Plant And Equipment Net 704.41 699.57 669.16 650.80 624.34 623.51 611.62 609.81 NA NA NA

Goodwill 1092.47 1116.00 1125.83 1120.32 1103.15 1114.18 1106.73 1115.94 NA NA NA

Indefinite Lived Intangible Assets Excluding Goodwill 101.24 106.44 109.16 107.94 107.94 110.14 108.76 107.97 NA NA NA

Intangible Assets Net Excluding Goodwill 503.75 543.06 582.14 598.84 608.64 640.79 656.57 643.37 NA NA NA

Finite Lived Intangible Assets Net 402.52 436.62 472.99 490.90 500.70 530.65 547.81 NA NA NA NA

Other Assets Noncurrent 47.13 38.31 27.49 12.87 9.21 8.83 9.28 9.30 NA NA NA

	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31
Amortization Of Intangible Assets	20.22	21.20	20.18	21.44	21.24	21.78	22.28	20.43	20.20	19.71	19.91
Property Plant And Equipment Net	704.41	699.57	669.16	650.80	624.34	623.51	611.62	609.81	NA	NA	NA
Goodwill	1092.47	1116.00	1125.83	1120.32	1103.15	1114.18	1106.73	1115.94	NA	NA	NA
Indefinite Lived Intangible Assets Excluding Goodwill	101.24	106.44	109.16	107.94	107.94	110.14	108.76	107.97	NA	NA	NA
Intangible Assets Net Excluding Goodwill	503.75	543.06	582.14	598.84	608.64	640.79	656.57	643.37	NA	NA	NA
Finite Lived Intangible Assets Net	402.52	436.62	472.99	490.90	500.70	530.65	547.81	NA	NA	NA	NA
Other Assets Noncurrent	47.13	38.31	27.49	12.87	9.21	8.83	9.28	9.30	NA	NA	NA

2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31

Liabilities Current 140.03 142.02 143.85 161.16 133.61 148.79 138.02 140.60 NA NA NA

Accounts Payable Current 60.73 65.27 55.22 72.87 51.81 63.15 57.17 52.40 NA NA NA

Other Accrued Liabilities Current 3.67 4.22 4.21 4.12 5.50 7.52 3.62 3.75 3.75 3.75 3.75

Taxes Payable Current 3.20 3.29 2.33 2.21 3.75 3.35 3.33 2.60 2.60 2.60 2.60

Accrued Income Taxes Current 7.35 6.88 4.37 6.70 10.91 11.07 7.38 10.45 NA NA NA

Accrued Liabilities Current 56.76 52.66 60.46 61.86 54.50 57.16 56.37 60.52 60.52 60.52 60.52

Contract With Customer Liability Current 5.35 6.86 12.93 8.67 4.87 5.54 5.96 6.06 NA NA NA

	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31
Liabilities Current	140.03	142.02	143.85	161.16	133.61	148.79	138.02	140.60	NA	NA	NA
Accounts Payable Current	60.73	65.27	55.22	72.87	51.81	63.15	57.17	52.40	NA	NA	NA
Other Accrued Liabilities Current	3.67	4.22	4.21	4.12	5.50	7.52	3.62	3.75	3.75	3.75	3.75
Taxes Payable Current	3.20	3.29	2.33	2.21	3.75	3.35	3.33	2.60	2.60	2.60	2.60
Accrued Income Taxes Current	7.35	6.88	4.37	6.70	10.91	11.07	7.38	10.45	NA	NA	NA
Accrued Liabilities Current	56.76	52.66	60.46	61.86	54.50	57.16	56.37	60.52	60.52	60.52	60.52
Contract With Customer Liability Current	5.35	6.86	12.93	8.67	4.87	5.54	5.96	6.06	NA	NA	NA

2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31

Long Term Debt 1746.56 1745.55 1763.55 1743.53 1742.58 1838.13 1864.16 1824.79 NA NA NA

Long Term Debt Noncurrent NA NA 1744.54 1743.53 NA NA 1837.58 1824.79 NA NA NA

Deferred Income Tax Liabilities Net 151.72 144.73 142.46 134.50 138.56 137.63 129.67 121.82 NA NA NA

Other Liabilities Noncurrent 15.35 15.67 16.19 16.27 19.30 18.91 18.80 17.51 NA NA NA

Operating Lease Liability Noncurrent 22.17 24.55 31.07 33.02 35.38 37.35 39.81 38.94 NA NA NA

	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31
Long Term Debt	1746.56	1745.55	1763.55	1743.53	1742.58	1838.13	1864.16	1824.79	NA	NA	NA
Long Term Debt Noncurrent	NA	NA	1744.54	1743.53	NA	NA	1837.58	1824.79	NA	NA	NA
Deferred Income Tax Liabilities Net	151.72	144.73	142.46	134.50	138.56	137.63	129.67	121.82	NA	NA	NA
Other Liabilities Noncurrent	15.35	15.67	16.19	16.27	19.30	18.91	18.80	17.51	NA	NA	NA
Operating Lease Liability Noncurrent	22.17	24.55	31.07	33.02	35.38	37.35	39.81	38.94	NA	NA	NA

2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31

Stockholders Equity 606.73 636.00 642.13 586.10 525.77 523.27 463.26 452.30 NA NA NA

Stockholders Equity Including Portion Attributable To Noncontrolling Interest 606.73 636.00 642.13 586.10 525.77 523.27 465.74 454.57 -662.00 -682.05 -715.63

Additional Paid In Capital 1186.62 1181.99 1177.10 1172.59 1171.10 1167.57 1169.85 1166.41 NA NA NA

Retained Earnings Accumulated Deficit -386.10 -411.19 -441.61 -472.25 -508.24 -535.69 -578.29 -589.13 NA NA NA

Accumulated Other Comprehensive Income Loss Net Of Tax -164.00 -105.01 -62.69 -83.57 -105.95 -77.47 -97.16 -93.84 NA NA NA

Treasury Stock Value 32.65 32.65 33.54 33.55 34.00 34.00 34.00 34.00 NA NA NA

Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 4.63 5.78 4.51 NA 3.54 2.41 3.44 NA 0.90 1.39 1.73

	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31
Stockholders Equity	606.73	636.00	642.13	586.10	525.77	523.27	463.26	452.30	NA	NA	NA
Stockholders Equity Including Portion Attributable To Noncontrolling Interest	606.73	636.00	642.13	586.10	525.77	523.27	465.74	454.57	-662.00	-682.05	-715.63
Additional Paid In Capital	1186.62	1181.99	1177.10	1172.59	1171.10	1167.57	1169.85	1166.41	NA	NA	NA
Retained Earnings Accumulated Deficit	-386.10	-411.19	-441.61	-472.25	-508.24	-535.69	-578.29	-589.13	NA	NA	NA
Accumulated Other Comprehensive Income Loss Net Of Tax	-164.00	-105.01	-62.69	-83.57	-105.95	-77.47	-97.16	-93.84	NA	NA	NA
Treasury Stock Value	32.65	32.65	33.54	33.55	34.00	34.00	34.00	34.00	NA	NA	NA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value	4.63	5.78	4.51	NA	3.54	2.41	3.44	NA	0.90	1.39	1.73

2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31

Net Cash Provided By Used In Operating Activities 67.78 58.29 49.97 66.35 80.94 78.10 56.16 21.84 46.05 47.00 5.69

Net Cash Provided By Used In Investing Activities -38.97 -35.71 -35.48 -72.26 -16.60 -24.45 -46.52 -18.77 -116.48 -10.45 -12.99

Net Cash Provided By Used In Financing Activities -0.40 -0.63 -0.45 -1.78 -103.41 -8.31 -3.78 -10.53 90.48 -55.83 49.31

	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31
Net Cash Provided By Used In Operating Activities	67.78	58.29	49.97	66.35	80.94	78.10	56.16	21.84	46.05	47.00	5.69
Net Cash Provided By Used In Investing Activities	-38.97	-35.71	-35.48	-72.26	-16.60	-24.45	-46.52	-18.77	-116.48	-10.45	-12.99
Net Cash Provided By Used In Financing Activities	-0.40	-0.63	-0.45	-1.78	-103.41	-8.31	-3.78	-10.53	90.48	-55.83	49.31

2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31

Net Cash Provided By Used In Operating Activities 67.78 58.29 49.97 66.35 80.94 78.10 56.16 21.84 46.05 47.00 5.69

Net Income Loss 25.09 30.42 30.64 36.00 27.44 42.60 10.84 -43.68 0.01 7.02 -1.96

Profit Loss 25.09 30.42 30.64 36.00 27.44 42.62 11.06 -43.39 0.63 7.25 -1.99

Increase Decrease In Accounts Receivable -5.36 7.53 6.39 10.61 -20.85 21.62 4.13 2.59 -9.34 4.38 0.43

Increase Decrease In Inventories 0.12 -4.69 -9.32 16.82 2.66 1.87 -1.10 3.39 -1.82 -6.91 1.55

Increase Decrease In Accounts Payable -3.37 2.75 -12.74 20.05 -15.37 8.46 6.62 1.83 1.10 -8.22 -0.73

Deferred Income Tax Expense Benefit 6.74 4.78 5.63 -11.85 4.63 7.14 -3.64 -23.18 8.06 -1.55 -6.68

Share Based Compensation 4.62 5.80 4.54 3.38 3.55 3.49 3.45 6.97 0.90 1.39 1.73

Amortization Of Financing Costs 1.42 1.42 1.41 1.37 1.54 1.58 1.66 2.80 3.00 2.85 2.98

	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31
Net Cash Provided By Used In Operating Activities	67.78	58.29	49.97	66.35	80.94	78.10	56.16	21.84	46.05	47.00	5.69
Net Income Loss	25.09	30.42	30.64	36.00	27.44	42.60	10.84	-43.68	0.01	7.02	-1.96
Profit Loss	25.09	30.42	30.64	36.00	27.44	42.62	11.06	-43.39	0.63	7.25	-1.99
Increase Decrease In Accounts Receivable	-5.36	7.53	6.39	10.61	-20.85	21.62	4.13	2.59	-9.34	4.38	0.43
Increase Decrease In Inventories	0.12	-4.69	-9.32	16.82	2.66	1.87	-1.10	3.39	-1.82	-6.91	1.55
Increase Decrease In Accounts Payable	-3.37	2.75	-12.74	20.05	-15.37	8.46	6.62	1.83	1.10	-8.22	-0.73
Deferred Income Tax Expense Benefit	6.74	4.78	5.63	-11.85	4.63	7.14	-3.64	-23.18	8.06	-1.55	-6.68
Share Based Compensation	4.62	5.80	4.54	3.38	3.55	3.49	3.45	6.97	0.90	1.39	1.73
Amortization Of Financing Costs	1.42	1.42	1.41	1.37	1.54	1.58	1.66	2.80	3.00	2.85	2.98

2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31

Net Cash Provided By Used In Investing Activities -38.97 -35.71 -35.48 -72.26 -16.60 -24.45 -46.52 -18.77 -116.48 -10.45 -12.99

Payments To Acquire Property Plant And Equipment 39.00 36.10 35.55 41.26 16.11 23.85 20.94 19.87 10.20 10.45 12.99

Payments To Acquire Productive Assets 39.00 NA NA 41.26 16.11 NA NA 19.87 10.20 NA NA

	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31
Net Cash Provided By Used In Investing Activities	-38.97	-35.71	-35.48	-72.26	-16.60	-24.45	-46.52	-18.77	-116.48	-10.45	-12.99
Payments To Acquire Property Plant And Equipment	39.00	36.10	35.55	41.26	16.11	23.85	20.94	19.87	10.20	10.45	12.99
Payments To Acquire Productive Assets	39.00	NA	NA	41.26	16.11	NA	NA	19.87	10.20	NA	NA

2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31

Net Cash Provided By Used In Financing Activities -0.40 -0.63 -0.45 -1.78 -103.41 -8.31 -3.78 -10.53 90.48 -55.83 49.31

		2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31
Net Cash Provided By Used In Financing Activities		-0.40	-0.63	-0.45	-1.78	-103.41	-8.31	-3.78	-10.53	90.48	-55.83	49.31

2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31

Revenues 248.70 266.64 236.75 241.25 226.16 251.92 212.15 216.84 200.03 213.09 188.20

Intersegment Elimination -7.40 -15.80 -15.50 -12.90 -3.70 -7.00 -10.50 -15.70 -3.00 -9.00 -10.90

Operating 248.70 266.64 236.75 241.25 226.16 251.92 212.15 216.84 200.03 213.09 188.20

Operating, Nelson Labs 55.91 58.37 53.29 54.37 52.08 57.61 55.08 53.31 53.46 50.57 47.30

Operating, Nordion 35.07 50.48 34.00 36.70 28.77 49.12 25.92 28.71 20.27 42.14 23.62

Operating, Sterigenics 157.72 157.79 149.46 150.18 145.31 145.18 131.15 134.82 126.30 120.37 117.28

Product 32.00 45.11 30.54 33.66 25.66 43.21 23.45 27.35 17.85 38.64 20.80

Service 216.70 221.53 206.22 207.59 200.50 208.71 188.70 189.50 182.18 174.44 167.41

Nelson Labs 55.91 58.37 53.29 54.37 52.08 57.61 55.08 53.32 53.46 50.57 47.30

Nordion 35.07 50.48 34.00 36.70 28.77 49.12 25.92 28.71 20.27 42.14 23.62

Sterigenics 157.72 157.79 149.46 150.18 145.31 145.18 131.15 134.82 126.30 120.37 117.28

Nelson Labs, Transferred Over Time 55.91 58.37 53.29 54.37 52.08 57.61 55.08 53.32 53.46 50.57 47.30

Nordion, Transferred At Point In Time 33.83 46.39 33.28 36.70 28.77 47.75 25.92 28.71 20.27 42.14 23.62

Nordion, Transferred Over Time 1.24 4.09 0.72 0.00 0.00 1.37 NA NA NA NA NA

Sterigenics, Transferred At Point In Time 157.72 157.79 149.46 150.18 145.31 145.18 131.15 134.82 126.30 120.37 117.28

Transferred At Point In Time 191.55 204.18 182.75 186.88 174.08 192.94 157.07 163.53 146.57 162.51 140.91

Transferred Over Time 57.15 62.46 54.01 54.37 52.08 58.98 55.08 53.32 53.46 50.57 47.30

Revenue From Contract With Customer Excluding Assessed Tax 248.70 266.64 236.75 241.25 226.16 251.92 212.15 216.84 200.03 213.09 188.20

Intersegment Elimination -7.40 -15.80 -15.50 -12.90 -3.70 -7.00 -10.50 -15.70 -3.00 -9.00 -10.90

Operating 248.70 266.64 236.75 241.25 226.16 251.92 212.15 216.84 200.03 213.09 188.20

Operating, Nelson Labs 55.91 58.37 53.29 54.37 52.08 57.61 55.08 53.31 53.46 50.57 47.30

Operating, Nordion 35.07 50.48 34.00 36.70 28.77 49.12 25.92 28.71 20.27 42.14 23.62

Operating, Sterigenics 157.72 157.79 149.46 150.18 145.31 145.18 131.15 134.82 126.30 120.37 117.28

Product 32.00 45.11 30.54 33.66 25.66 43.21 23.45 27.35 17.85 38.64 20.80

Service 216.70 221.53 206.22 207.59 200.50 208.71 188.70 189.50 182.18 174.44 167.41

Nelson Labs 55.91 58.37 53.29 54.37 52.08 57.61 55.08 53.32 53.46 50.57 47.30

Nordion 35.07 50.48 34.00 36.70 28.77 49.12 25.92 28.71 20.27 42.14 23.62

Sterigenics 157.72 157.79 149.46 150.18 145.31 145.18 131.15 134.82 126.30 120.37 117.28

Nelson Labs, Transferred Over Time 55.91 58.37 53.29 54.37 52.08 57.61 55.08 53.32 53.46 50.57 47.30

Nordion, Transferred At Point In Time 33.83 46.39 33.28 36.70 28.77 47.75 25.92 28.71 20.27 42.14 23.62

Nordion, Transferred Over Time 1.24 4.09 0.72 0.00 0.00 1.37 NA NA NA NA NA

Sterigenics, Transferred At Point In Time 157.72 157.79 149.46 150.18 145.31 145.18 131.15 134.82 126.30 120.37 117.28

Transferred At Point In Time 191.55 204.18 182.75 186.88 174.08 192.94 157.07 163.53 146.57 162.51 140.91

Transferred Over Time 57.15 62.46 54.01 54.37 52.08 58.98 55.08 53.32 53.46 50.57 47.30

	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31
Revenues	248.70	266.64	236.75	241.25	226.16	251.92	212.15	216.84	200.03	213.09	188.20
Intersegment Elimination	-7.40	-15.80	-15.50	-12.90	-3.70	-7.00	-10.50	-15.70	-3.00	-9.00	-10.90
Operating	248.70	266.64	236.75	241.25	226.16	251.92	212.15	216.84	200.03	213.09	188.20
Operating, Nelson Labs	55.91	58.37	53.29	54.37	52.08	57.61	55.08	53.31	53.46	50.57	47.30
Operating, Nordion	35.07	50.48	34.00	36.70	28.77	49.12	25.92	28.71	20.27	42.14	23.62
Operating, Sterigenics	157.72	157.79	149.46	150.18	145.31	145.18	131.15	134.82	126.30	120.37	117.28
Product	32.00	45.11	30.54	33.66	25.66	43.21	23.45	27.35	17.85	38.64	20.80
Service	216.70	221.53	206.22	207.59	200.50	208.71	188.70	189.50	182.18	174.44	167.41
Nelson Labs	55.91	58.37	53.29	54.37	52.08	57.61	55.08	53.32	53.46	50.57	47.30
Nordion	35.07	50.48	34.00	36.70	28.77	49.12	25.92	28.71	20.27	42.14	23.62
Sterigenics	157.72	157.79	149.46	150.18	145.31	145.18	131.15	134.82	126.30	120.37	117.28
Nelson Labs, Transferred Over Time	55.91	58.37	53.29	54.37	52.08	57.61	55.08	53.32	53.46	50.57	47.30
Nordion, Transferred At Point In Time	33.83	46.39	33.28	36.70	28.77	47.75	25.92	28.71	20.27	42.14	23.62
Nordion, Transferred Over Time	1.24	4.09	0.72	0.00	0.00	1.37	NA	NA	NA	NA	NA
Sterigenics, Transferred At Point In Time	157.72	157.79	149.46	150.18	145.31	145.18	131.15	134.82	126.30	120.37	117.28
Transferred At Point In Time	191.55	204.18	182.75	186.88	174.08	192.94	157.07	163.53	146.57	162.51	140.91
Transferred Over Time	57.15	62.46	54.01	54.37	52.08	58.98	55.08	53.32	53.46	50.57	47.30
Revenue From Contract With Customer Excluding Assessed Tax	248.70	266.64	236.75	241.25	226.16	251.92	212.15	216.84	200.03	213.09	188.20
Intersegment Elimination	-7.40	-15.80	-15.50	-12.90	-3.70	-7.00	-10.50	-15.70	-3.00	-9.00	-10.90
Operating	248.70	266.64	236.75	241.25	226.16	251.92	212.15	216.84	200.03	213.09	188.20
Operating, Nelson Labs	55.91	58.37	53.29	54.37	52.08	57.61	55.08	53.31	53.46	50.57	47.30
Operating, Nordion	35.07	50.48	34.00	36.70	28.77	49.12	25.92	28.71	20.27	42.14	23.62
Operating, Sterigenics	157.72	157.79	149.46	150.18	145.31	145.18	131.15	134.82	126.30	120.37	117.28
Product	32.00	45.11	30.54	33.66	25.66	43.21	23.45	27.35	17.85	38.64	20.80
Service	216.70	221.53	206.22	207.59	200.50	208.71	188.70	189.50	182.18	174.44	167.41
Nelson Labs	55.91	58.37	53.29	54.37	52.08	57.61	55.08	53.32	53.46	50.57	47.30
Nordion	35.07	50.48	34.00	36.70	28.77	49.12	25.92	28.71	20.27	42.14	23.62
Sterigenics	157.72	157.79	149.46	150.18	145.31	145.18	131.15	134.82	126.30	120.37	117.28
Nelson Labs, Transferred Over Time	55.91	58.37	53.29	54.37	52.08	57.61	55.08	53.32	53.46	50.57	47.30
Nordion, Transferred At Point In Time	33.83	46.39	33.28	36.70	28.77	47.75	25.92	28.71	20.27	42.14	23.62
Nordion, Transferred Over Time	1.24	4.09	0.72	0.00	0.00	1.37	NA	NA	NA	NA	NA
Sterigenics, Transferred At Point In Time	157.72	157.79	149.46	150.18	145.31	145.18	131.15	134.82	126.30	120.37	117.28
Transferred At Point In Time	191.55	204.18	182.75	186.88	174.08	192.94	157.07	163.53	146.57	162.51	140.91
Transferred Over Time	57.15	62.46	54.01	54.37	52.08	58.98	55.08	53.32	53.46	50.57	47.30

Plots across concepts

IncomeStatement

Expenses

Balance Sheet

Assets

Current Assets

NonCurrent Assets

Liabilities

Current Liabilities

Noncurrent Liabilities

Stockholders Equity

CashFlow

NetCashProvidedByUsedInOperatingActivities

NetCashProvidedByUsedInInvestingActivities

NetCashProvidedByUsedInFinancingActivities

OperatingLeaseLiability

FiniteLivedIntangibleAssets

InventoryNet

AccountsReceivable

Line plots across dimensions of each concept

Cost Ratio
us-gaap:ProductOrService
(None,)

TTM Greenblatt ROC
_
(None,)

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:StatementBusinessSegments, us-gaap:TimingOfTransferOfGoodOrService
(None, 'us-gaap:TransferredOverTime')

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:StatementBusinessSegments, us-gaap:TimingOfTransferOfGoodOrService
(None, 'us-gaap:TransferredAtPointInTime')

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:TimingOfTransferOfGoodOrService
(None,)

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:StatementBusinessSegments
(None,)

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments
('us-gaap:Operating', None)

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ConsolidationItems
(None,)

us-gaap:Revenues
us-gaap:ProductOrService
(None,)

us-gaap:Revenues
us-gaap:StatementBusinessSegments, us-gaap:TimingOfTransferOfGoodOrService
(None, 'us-gaap:TransferredOverTime')

us-gaap:Revenues
us-gaap:StatementBusinessSegments, us-gaap:TimingOfTransferOfGoodOrService
(None, 'us-gaap:TransferredAtPointInTime')

us-gaap:Revenues
us-gaap:TimingOfTransferOfGoodOrService
(None,)

us-gaap:Revenues
us-gaap:StatementBusinessSegments
(None,)

us-gaap:Revenues
us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments
('us-gaap:Operating', None)

us-gaap:Revenues
us-gaap:ConsolidationItems
(None,)

us-gaap:CostOfRevenue
us-gaap:ProductOrService
(None,)

us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:AwardType, us-gaap:PlanName
(None, 'shc:A2020OmnibusIncentivePlan')

us-gaap:OtherComprehensiveIncomeLossNetOfTax
us-gaap:StatementEquityComponents
(None,)

us-gaap:AmortizationOfIntangibleAssets
us-gaap:FiniteLivedIntangibleAssetsByMajorClass, us-gaap:IncomeStatementLocation
('us-gaap:OtherIntangibleAssets', None)

us-gaap:Goodwill
us-gaap:BusinessAcquisition
(None,)

us-gaap:Goodwill
us-gaap:StatementBusinessSegments
(None,)

us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
us-gaap:IndefiniteLivedIntangibleAssetsByMajorClass
(None,)

us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
us-gaap:StatementEquityComponents
(None,)

us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
us-gaap:StatementEquityComponents
(None,)

us-gaap:PaymentsToAcquireProductiveAssets
us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments
('us-gaap:Operating', None)

us-gaap:PaymentsToAcquireProductiveAssets
us-gaap:StatementBusinessSegments
(None,)